Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5 Highlights From the Week’s Financials News: H.J. Heinz Company (HNZ) and More

The financials sector is never short on news, but if you’re short on time, let me do the leg work for you. I’ve dug through the Fool’s financial sector coverage over the past week to highlight three stories you don’t want to overlook.

Read on for this week’s big news.

1. Did Buffett Overpay for Heinz?
It’s true. Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK.A), along with investment firm 3G Capital, has purchased H.J. Heinz Company (NYSE:HNZ). As many analysts have noted, it’s a business firmly situated in Buffett’s preferred wheelhouse — a stable, mature company, an iconic brand, and a familiar product. But Alex Dumortier wonders if the Oracle overpaid for the pleasure? (Seriously, did he?)

H.J. Heinz Company (NYSE:HNZ)2. The Single Biggest Threat to Bank of America Corp (NYSE:BAC) Today
In five well-researched installments, John Maxfield breaks down Bank of America Corp (NYSE:BAC)‘s legal troubles resulting from the bank’s infamous 2008 acquisition of Countrywide Financial and all of its toxic subprime loans — lawsuit after lawsuit (after lawsuit) have put B of A in danger of “death by a thousand cuts,” Maxfield suggests.

If you’re as confused as the rest of us about what is really going on, click through to the first of the series, where Maxfield leads us through the legal labyrinth and shares the conclusion he’s come to after doing the research.

3. Chimera Lives to Fight (Yet Another) Day
Remember Chimera Investment Corporation (NYSE:CIM)‘s  problems with submitting its financial statements to the SEC? The company had until January 15 to submit the missing documents, but when that day came, the SEC extended the deadline to February 15. Well, that day has come and gone, too, and Chimera has lucked out again — the SEC has again granted it an extension, this time until March 15.

There may be a glimmer of hope among the mREIT’s fuzzy accounting, John Maxfield suggests, in the form of some high-profile investments by BlackRock, Inc. (NYSE:BLK), Goldman Sachs Group, Inc. (NYSE:GS), and Wells Fargo & Company (NYSE:WFC), and billionaire Leon Cooperman.

4. Why Citigroup Inc. (NYSE:C) is Making Me Nervous
John Grgurich takes a look at what Citigroup Inc. (NYSE:C) says it’s going to do with the cash it set aside to deal with troubled mortgages. Will the bank spend the money it needs to spend to cover its debts and return to healthy profitability, or is it holding off for a settlement with Fannie Mae and Freddie Mac akin to the one Bank of America made with Fannie?

Grgurich has a message for Citi Chief Financial Officer John Gerspach: “Straighten out Citigroup’s books once and for all, Mr. Gerspach, and the investment dollars will follow.”

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.